Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Institutional buyer or Fund @ $5.50 US
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Bigboyoneon Sep 06, 2016 1:37pm
83 Views
Post# 25210607

RE:RE:RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 US

RE:RE:RE:RE:RE:RE:Institutional buyer or Fund @ $5.50 USI hope I am wrong,...I would be the firs to admit it.. I have been with this situation too long (my own fault, I believed the hype)
This stoc k does not follow technicals or fundamentals (Overbought or sold). To some degree it wwill follow moving averages.
This Stock does follow market and sector pressure and is manipulated by the Instituition (s) holding this stock. Thats a fact. I cannot prove it, and I could be sued as well..but I see it with in the share flow.  I was on a trading desk for years.
With all the hype we should have been in lows $7.00+, Look at the volume picking up here, Do you know any small shareholder selling before our anticipated aproval date? I dont..Who would be selling here? Who? 
My 2 cents worth, and for what its worth, if we do get a possitive FDA YOSPRALA announcement, I do anticipate a quick up and a few days  right after selling, and we are also coming into Tax loss season (October-December)..I dont see any big move until 2017, if it is to happen.....I hope I am wrong..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities